Fundraising FoxDynamk Capital — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
Alpenglow Biosciences develops AI-enabled 3D tissue imaging and spatial profiling platforms for researchers and clinical teams in pathology and diagnostics.
AI & Machine LearningBiotechDeep TechMedical Devices
Nicholas Reder(MD, MPH)inJonathan Liu(Co-founder)inAdam Glaser(Co-founder)inLarry True(Co-founder)
Curi Bio provides a preclinical drug development platform combining 3D human tissue models of disease (cardiac and skeletal muscle), biosystems for functional analysis, and AI/ML-based insights to assess drug safety, efficacy, and potency.
AI & Machine LearningBiotechMedical Devices
Elliot Fisher(Cofounder)in
Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases.
AI & Machine LearningBiotechMedical DevicesNew York, US
Martin Akerman, PhD(CEO & Co-founder)Martin Akerman(Founder)inMaria Luisa Pineda(Founder)in
Co-investorsDolby Family VenturesHAWKTAILM12 (Microsoft's Venture Fund)Madrona Venture GroupRed Cell IncubationThird Kind Venture Capital
Vectron Biosolutions develops custom bacterial production strains for protein manufacturing, using proprietary technologies (VB Expression, VB Evolution, and VB Secretion) to engineer E. coli and other microorganisms for clients in the pharmaceutical and biotech industries.
BiotechDeep TechTrondheim, NO
Svein Valla(Professor)Trond Erik Vee Aune(C.E.O.)in
Vernal Biosciences is an mRNA contract development and manufacturing organization (CDMO) that produces high-quality mRNA for research and therapeutic development.
Advanced ManufacturingBiotechDeep TechMedical DevicesColchester, US
Christian Cobaugh(Chief Scientific Officer and Founder)in
BoardErrik Anderson(Director)
Virica is a biotech company that develops small-molecule "Viral Sensitizers" which temporarily reduce host cell defenses during viral vector production to increase yield, quality, and scalability.
Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesOttawa, CA
Jean-Simon Diallo(Founder)inKen Newport(Executive Officer)inElla Korets-Smith(Executive Officer)in
Co-investorsAvant Bio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.